About
Dr. Vincent Daien is a Clinical Professor at the Save Sight Institute, University of Sydney's Faculty of Medicine and Health. His research focuses on ophthalmic conditions including glaucoma, macular degeneration, diabetic retinopathy, and retinal imaging. Key areas of investigation include anti-VEGF therapies, retinal microcirculation, and clinical registry data analysis.
He has contributed to over 50 peer-reviewed publications since 2016, with recent work emphasizing real-world evidence for anti-VEGF treatments in age-related macular degeneration and diabetic macular edema. His studies often involve large observational datasets like the Fight Retinal Blindness! Project and Save Sight Registries.
Dr. Daien's work bridges clinical practice and research, addressing treatment efficacy, patient outcomes, and healthcare delivery optimization. Notable contributions include evaluations of cyclophotocoagulation for glaucoma, keratoconus risk factors, and quality-of-life impacts of eye diseases.
His research collaborations span institutions globally, with a focus on translational studies that inform clinical guidelines and improve patient management strategies.
